Immune to Cancer: The CRI Blog
-
AACR Report Highlights Cancer Immunotherapy
The AACR Cancer Progress Report provides a "state-of-the-union" look at where we are in cancer research.
-
Coast to Coast for a Cure
Cyclist Joel Paula biked 4,000 miles to raise money for the Cancer Research Institute, and to prove…
-
FDA Approves New Cancer Immunotherapy
Merck's new immunotherapy, Keytruda (pembrolizumab), was approved today by the FDA, making it the first PD-1 inhibitor…
-
CRI Names Winners of Top Scientific Prize
Four scientists to be honored with the 2014 Coley Award for their contributions to the discovery of…
-
A Pilgrimage in Spain to Fight All Cancers
Having had four brothers battle cancer, David was inspired to make a 800km fundraising trek a journey…
-
When AIDS Was a Cancer
Before AIDS was recognized as an immune disorder, it was seen as a cancer. Find out what…
-
Two Immunotherapies Clear Important Regulatory Hurdles
The anti-PD-1 drug nivolumab receives the go-ahead for use in Japan, while in the U.S., CAR-T cells…
-
Making Pancreatic Cancer a Target for Immunotherapy
Researchers show that pancreatic cancer, long known to resist immunotherapy, can be made immunogenic after all.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.